153 related articles for article (PubMed ID: 11137238)
1. Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres.
Johansen P; Estevez F; Zurbriggen R; Merkle HP; Glück R; Corradin G; Gander B
Vaccine; 2000 Dec; 19(9-10):1047-54. PubMed ID: 11137238
[TBL] [Abstract][Full Text] [Related]
2. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs.
Johansen P; Moon L; Tamber H; Merkle HP; Gander B; Sesardic D
Vaccine; 1999 Sep; 18(3-4):209-15. PubMed ID: 10506644
[TBL] [Abstract][Full Text] [Related]
4. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
5. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
Jung T; Koneberg R; Hungerer KD; Kissel T
Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
[TBL] [Abstract][Full Text] [Related]
6. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T
Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276
[TBL] [Abstract][Full Text] [Related]
7. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
[TBL] [Abstract][Full Text] [Related]
8. Determinants of release rate of tetanus vaccine from polyester microspheres.
Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
10. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.
Johansen P; Men Y; Audran R; Corradin G; Merkle HP; Gander B
Pharm Res; 1998 Jul; 15(7):1103-10. PubMed ID: 9688067
[TBL] [Abstract][Full Text] [Related]
11. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
Kostanski JW; Thanoo BC; DeLuca PP
Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
14. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs.
Johansen P; Tamber H; Merkle HP; Gander B
Eur J Pharm Biopharm; 1999 May; 47(3):193-201. PubMed ID: 10382103
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD
Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474
[TBL] [Abstract][Full Text] [Related]
16. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
[TBL] [Abstract][Full Text] [Related]
17. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
[TBL] [Abstract][Full Text] [Related]
18. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.
Prior S; Gander B; Blarer N; Merkle HP; Subirá ML; Irache JM; Gamazo C
Eur J Pharm Sci; 2002 Mar; 15(2):197-207. PubMed ID: 11849917
[TBL] [Abstract][Full Text] [Related]
19. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.
Gupta RK; Chang AC; Griffin P; Rivera R; Guo YY; Siber GR
Vaccine; 1997; 15(6-7):672-8. PubMed ID: 9178469
[TBL] [Abstract][Full Text] [Related]
20. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
Johansen P; Corradin G; Merkle HP; Gander B
J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
